Edward Dulac
Director of Finance/CFO bei FATE THERAPEUTICS, INC.
Vermögen: 744 856 $ am 31.03.2024
Profil
Derzeit bekleidet Edward J. Dulac die Position des Chief Financial Officer & Accounting Officer bei Fate Therapeutics, Inc. In der Vergangenheit war er Principal bei CVS, Inc. (Maryland), Vice President-Business Development & Strategy bei Celgene Corp., Principal bei Pfizer (St. Louis), Principal bei Brooks Eckerd Pharmacy, Research Analyst bei Barclays Capital, Inc. und Research Analyst bei Barclays Capital Securities Ltd. Er erhielt einen Undergraduate-Abschluss von der University of Pittsburgh und einen MBA von der Kelley School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
FATE THERAPEUTICS, INC.
0,10% | 04.03.2024 | 101 479 ( 0,10% ) | 744 856 $ | 31.03.2024 |
Aktive Positionen von Edward Dulac
Unternehmen | Position | Beginn |
---|---|---|
FATE THERAPEUTICS, INC. | Director of Finance/CFO | 17.08.2020 |
Ehemalige bekannte Positionen von Edward Dulac
Unternehmen | Position | Ende |
---|---|---|
CELGENE | Corporate Officer/Principal | 01.02.2020 |
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Barclays Capital Securities Ltd. (BCS) is the brokerage subsidiary of Barclays Bank plc, which is owned by Barclays Plc (LON: BARC), an international financial services group in Great Britain. The firm was founded in 1985 and is headquartered in London with offices worldwide. BCS provides prime brokerage services which include equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics. | Analyst-Equity | 25.07.2011 |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Corporate Officer/Principal | 30.11.2007 |
Brooks Eckerd Pharmacy | Corporate Officer/Principal | 30.06.2001 |
CVS, Inc. (Maryland)
CVS, Inc. (Maryland) Other Consumer ServicesConsumer Services CVS, Inc. (Maryland) provides engineering, maintenance, and control programming services for video, audio, and control system. The company was founded in 1989 and is headquartered in Mount Airy, MD. | Corporate Officer/Principal | 30.09.1999 |
Ausbildung von Edward Dulac
University of Pittsburgh | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Barclays Capital Securities Ltd. (BCS) is the brokerage subsidiary of Barclays Bank plc, which is owned by Barclays Plc (LON: BARC), an international financial services group in Great Britain. The firm was founded in 1985 and is headquartered in London with offices worldwide. BCS provides prime brokerage services which include equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics. | Finance |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
Brooks Eckerd Pharmacy | |
CVS, Inc. (Maryland)
CVS, Inc. (Maryland) Other Consumer ServicesConsumer Services CVS, Inc. (Maryland) provides engineering, maintenance, and control programming services for video, audio, and control system. The company was founded in 1989 and is headquartered in Mount Airy, MD. | Consumer Services |